Quick Takeaways
- RTW INVESTMENTS, LP filed SCHEDULE 13G for Aquestive Therapeutics, Inc. Common Stock, $0.001 par value (AQST).
- Disclosed ownership: 5.2%.
- Date of event: 30 Sep 2025.
RTW INVESTMENTS, LP - 30 Sep 2025 SCHEDULE 13G Report for Aquestive Therapeutics, Inc. Common Stock, $0.001 par value (AQST)
- Filing Manager
- RTW INVESTMENTS, LP
- Reporting Manager
- RTW Investments, LP
- Symbol
- AQST
- Shares outstanding
- 120,192,308 shares
- Disclosed Ownership
- 6,250,000 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Nov 2025, 08:24:27 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"RTW INVESTMENTS, LP disclosed 5.2% ownership in Aquestive Therapeutics, Inc. Common Stock, $0.001 par value (AQST) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 08:24.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RTW Investments, LP | 5.2% | 6,250,000 | 0 | 6,250,000 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D., Managing Partner | |
| Roderick Wong | 5.2% | 6,250,000 | 0 | 6,250,000 | s/ Roderick Wong, M.D. | Roderick Wong, M.D. |